Long-term change in MMSE by treatment arm. Clinically significant change in MMSE score at key evaluations for patients without tumor progression
. | Year . | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
. | 0 . | 1 . | 2 . | 3 . | 5 . | 7 . | 8 . | 10 . | 12 . | 15 . |
Alive | 203 | 192 | 178 | 166 | 132 | 113 | 102 | 85 | 68 | 44 |
Alive, baseline MMSE | 187 | 178 | 165 | 153 | 121 | 103 | 94 | 78 | 62 | 39 |
Alive, prog-free, baseline MMSE | 187 | 162 | 141 | 126 | 91 | 69 | 63 | 45 | 34 | 18 |
Abnormal baseline MMSE | 47 | 35 | 26 | 22 | 12 | 7 | 7 | 4 | 3 | 3 |
n with MMSE | 47 | 25 | 19 | 16 | 7 | 2 | 4 | 2 | 1 | 1 |
Decrease | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | |
Increase | 10 | 9 | 6 | 1 | 1 | 2 | 1 | 0 | 0 | |
Stable | 14 | 9 | 9 | 6 | 1 | 2 | 1 | 0 | 1 | |
Normal baseline MMSE | 140 | 127 | 115 | 104 | 79 | 62 | 56 | 41 | 31 | 15 |
n with MMSE | 140 | 97 | 87 | 69 | 42 | 20 | 20 | 12 | 3 | 1 |
Decrease | 7 | 3 | 2 | 2 | 1 | 1 | 0 | 0 | 0 | |
Stable | 90 | 84 | 67 | 40 | 19 | 19 | 12 | 3 | 1 |
. | Year . | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
. | 0 . | 1 . | 2 . | 3 . | 5 . | 7 . | 8 . | 10 . | 12 . | 15 . |
Alive | 203 | 192 | 178 | 166 | 132 | 113 | 102 | 85 | 68 | 44 |
Alive, baseline MMSE | 187 | 178 | 165 | 153 | 121 | 103 | 94 | 78 | 62 | 39 |
Alive, prog-free, baseline MMSE | 187 | 162 | 141 | 126 | 91 | 69 | 63 | 45 | 34 | 18 |
Abnormal baseline MMSE | 47 | 35 | 26 | 22 | 12 | 7 | 7 | 4 | 3 | 3 |
n with MMSE | 47 | 25 | 19 | 16 | 7 | 2 | 4 | 2 | 1 | 1 |
Decrease | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | |
Increase | 10 | 9 | 6 | 1 | 1 | 2 | 1 | 0 | 0 | |
Stable | 14 | 9 | 9 | 6 | 1 | 2 | 1 | 0 | 1 | |
Normal baseline MMSE | 140 | 127 | 115 | 104 | 79 | 62 | 56 | 41 | 31 | 15 |
n with MMSE | 140 | 97 | 87 | 69 | 42 | 20 | 20 | 12 | 3 | 1 |
Decrease | 7 | 3 | 2 | 2 | 1 | 1 | 0 | 0 | 0 | |
Stable | 90 | 84 | 67 | 40 | 19 | 19 | 12 | 3 | 1 |
Long-term change in MMSE by treatment arm. Clinically significant change in MMSE score at key evaluations for patients without tumor progression
. | Year . | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
. | 0 . | 1 . | 2 . | 3 . | 5 . | 7 . | 8 . | 10 . | 12 . | 15 . |
Alive | 203 | 192 | 178 | 166 | 132 | 113 | 102 | 85 | 68 | 44 |
Alive, baseline MMSE | 187 | 178 | 165 | 153 | 121 | 103 | 94 | 78 | 62 | 39 |
Alive, prog-free, baseline MMSE | 187 | 162 | 141 | 126 | 91 | 69 | 63 | 45 | 34 | 18 |
Abnormal baseline MMSE | 47 | 35 | 26 | 22 | 12 | 7 | 7 | 4 | 3 | 3 |
n with MMSE | 47 | 25 | 19 | 16 | 7 | 2 | 4 | 2 | 1 | 1 |
Decrease | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | |
Increase | 10 | 9 | 6 | 1 | 1 | 2 | 1 | 0 | 0 | |
Stable | 14 | 9 | 9 | 6 | 1 | 2 | 1 | 0 | 1 | |
Normal baseline MMSE | 140 | 127 | 115 | 104 | 79 | 62 | 56 | 41 | 31 | 15 |
n with MMSE | 140 | 97 | 87 | 69 | 42 | 20 | 20 | 12 | 3 | 1 |
Decrease | 7 | 3 | 2 | 2 | 1 | 1 | 0 | 0 | 0 | |
Stable | 90 | 84 | 67 | 40 | 19 | 19 | 12 | 3 | 1 |
. | Year . | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
. | 0 . | 1 . | 2 . | 3 . | 5 . | 7 . | 8 . | 10 . | 12 . | 15 . |
Alive | 203 | 192 | 178 | 166 | 132 | 113 | 102 | 85 | 68 | 44 |
Alive, baseline MMSE | 187 | 178 | 165 | 153 | 121 | 103 | 94 | 78 | 62 | 39 |
Alive, prog-free, baseline MMSE | 187 | 162 | 141 | 126 | 91 | 69 | 63 | 45 | 34 | 18 |
Abnormal baseline MMSE | 47 | 35 | 26 | 22 | 12 | 7 | 7 | 4 | 3 | 3 |
n with MMSE | 47 | 25 | 19 | 16 | 7 | 2 | 4 | 2 | 1 | 1 |
Decrease | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | |
Increase | 10 | 9 | 6 | 1 | 1 | 2 | 1 | 0 | 0 | |
Stable | 14 | 9 | 9 | 6 | 1 | 2 | 1 | 0 | 1 | |
Normal baseline MMSE | 140 | 127 | 115 | 104 | 79 | 62 | 56 | 41 | 31 | 15 |
n with MMSE | 140 | 97 | 87 | 69 | 42 | 20 | 20 | 12 | 3 | 1 |
Decrease | 7 | 3 | 2 | 2 | 1 | 1 | 0 | 0 | 0 | |
Stable | 90 | 84 | 67 | 40 | 19 | 19 | 12 | 3 | 1 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.